AK-CLRN1

N/A

Report date: 2024/11/15 17:02:25

Base Information

Drug NameAK-CLRN1
Drug Alias NameAKCLRN1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionClarin-1 stimulants
TargetsClarin-1
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkouos Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyAkouos Inc
Inactive CompaniesN/A
Active IndicationsUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A